SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing a surge, driven by factors like potential Fed rate cuts and renewed focus from Elon Musk. Community discussions revolve around the stock potentially reaching $400 soon, with some anticipating a gamma squeeze. Others caution about overvaluation and potential pullbacks, highlighting the stock's volatile nature.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid heated discussions and political rhetoric following a shooting involving conservative activist Charlie Kirk. The community is divided, with some users trading accusations related to political affiliations and alleged radicalization, while others are focusing on the Epstein files and calling for their release. Broader discussions touch upon gun control, media influence, and the state of political discourse.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community anticipates a potential ETF launch, though some traders suggest the launch may be delayed. Bullish sentiment is fueled by speculation of increased institutional investment, with some setting targets and calling for a push to new highs. Despite the optimism, some traders caution against a potential "sell the news" event.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

ATYR is trending due to anticipation surrounding upcoming data release for their Phase 3 trial, with community members actively discussing potential outcomes and comparing the situation to previous short squeeze events like GME. Bullish sentiment centers around the belief in positive data and a potential short squeeze, while bears, including figures like Martin Shkreli, express skepticism and anticipate a negative outcome. The discussion includes technical analysis, potential price targets, and the overall risk/reward profile of this binary event.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK is trending due to a recent $20 million investment agreement, sparking discussions about potential market capitalization changes and future news catalysts. The community is actively debating the implications of this investment, alongside speculation about upcoming events and their effect on the stock's price. Some traders are also highlighting the stock's low float and high short interest as potential drivers for significant price movement.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid reports the Trump administration may pull COVID-19 vaccines from the market, sparking intense debate about the future of mRNA technology and its impact on the company. The community is discussing the potential for a short squeeze, while weighing the significance of pipeline developments against political and regulatory headwinds.  Some traders are also expressing concerns about the potential impact from negative public sentiment surrounding vaccines.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to regulatory clearance for its Oxford Ionics acquisition, sparking discussions about the deal's implications and potential synergies. Community members are debating whether the stock is overvalued and if it can maintain its gains, while also weighing the broader prospects of the quantum computing sector. Some traders are eyeing shorting opportunities, while others express bullish sentiment, anticipating further catalysts.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending amid discussions around potential links between COVID vaccines and child deaths, sparking debates over vaccine safety and potential liabilities. The community is weighing the impact of these concerns against the broader context of Pfizer's pipeline and dividend yield, with some calling for leadership changes. Some are considering the potential rotation to big pharma as the market corrects.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation of a potential acquisition by Paramount Skydance, driving significant interest and trading volume. Community discussions revolve around the potential buyout price, strategic implications of combining content libraries, and possible bidding war scenarios involving other major players like Apple and Amazon. Traders are weighing the potential synergies, debt considerations, and the possibility of a bidding war that could significantly impact the stock's valuation.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor (OPEN) is trending as the community debates a recent pullback following a significant run-up, with discussions around profit-taking, short positions, and potential support levels. Some traders are pointing to a new CEO and potential layoffs as key factors, while others remain bullish, anticipating a continued upward trend and potential short squeeze. The stock's high volatility and recent price action are fueling active discussions among investors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in Sensus Healthcare (SRTS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates

Sensus Healthcare (SRTS) delivered earnings and revenue surprises of -700.00% and -16.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Steris (STE) Tops Q1 Earnings and Revenue Estimates

Steris (STE) delivered earnings and revenue surprises of +0.86% and +2.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -58.33% and -5.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Sensus Healthcare, Inc. (SRTS) Stock Drops Despite Market Gains: Important Facts to Note

In the most recent trading session, Sensus Healthcare, Inc. (SRTS) closed at $5.51, indicating a -2.48% shift from the previous trading day.

Why Sensus Healthcare, Inc. (SRTS) Outpaced the Stock Market Today

Sensus Healthcare, Inc. (SRTS) reached $4.44 at the closing of the latest trading day, reflecting a +2.54% change compared to its last close.

Sensus Healthcare, Inc. (SRTS) Dips More Than Broader Market: What You Should Know

Sensus Healthcare, Inc. (SRTS) closed at $4.16 in the latest trading session, marking a -9.17% move from the prior day.

Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors

Sensus Healthcare, Inc. (SRTS) closed at $4.64 in the latest trading session, marking a -2.11% move from the prior day.

Sensus Healthcare, Inc. (SRTS) Stock Moves 1.91%: What You Should Know

In the closing of the recent trading day, Sensus Healthcare, Inc. (SRTS) stood at $4.80, denoting a +1.91% move from the preceding trading day.

Is It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views?

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Sensus Healthcare Inc

Buying for a long-term investment

Buying for a short-term trade

Trading around the volatility

Avoiding it

$GEMI IPO day is upon us, how are you playing it?

Stocktwits

Gemini Space Station

 IPO day is upon us, how are you playing it?

SRTS
Sensus Healthcare Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SRTS News

SRTS Sensus Healthcare Inc